Mashup Score:4
Cardiac Interventions TodayTwitter Feed: ACC Media Center
Mashup Score:3
MedPageTodayWhich Advanced HF Patients Are Entresto-Intolerant in the Real World? - 1 day
Mashup Score:3
1 in 6 dropped out from the LIFE trial because of side...
-
New research in #JACCHF found that participants in the LIFE trial w/ 4 or more risk factors had a 50% higher chance of sacubitril & valsartan intolerance. @nicolejlou discusses the multivariable predictors of intolerance in @medpagetoday: https://t.co/Fi21WjVknz #HeartFailure - view on twitter
Mashup Score:2
MedPageTodayBreast Cancer Survivors Who Work Out See Heart Benefits - 1 week
Mashup Score:2
Lower risk of abnormal GLS even in moderately active...
-
New data in #JACCCardioOnc suggests that among long-term breast cancer survivors, physical activity was associated w/ better global longitudinal strain but not #LVEF. Read more in @medpagetoday: https://t.co/BNcNwqzRu7 @MichalRuprecht - view on twitter
Mashup Score:2
Cardiovascular Research TechnologiesHydroxychloroquine and methotrexate showed similar risks of sudden cardiac arrest (SCA) or ventricular arrythmia (VA) in older patients with rheumatoid arthritis (RA); however, hydroxychloroquine...
-
A new #JACC analysis of Medicare data found that hydroxychloroquine and methotrexate had similar risks of #SuddenCardiacArrest or ventricular arrythmia in older patients w/ rheumatoid arthritis. Read more in @CRT_meeting: https://t.co/92ANUkxRcX #cvPrev - view on twitter
Mashup Score:2
Connecticut PostThe promise of meditation for the heart and mind - 1 week
Mashup Score:2
Meditation, as a religious practice or mystic experience, may be as old as...
-
Does meditation benefit ❤️ health? A #JACC study found that yoga, which features meditation, could improve symptoms for #AFib patients. Lately, this topic has garnered further scientific attention and @connpost delves into the key findings here: https://t.co/tYdHjns5vU - view on twitter
Mashup Score:2
MedscapeHydroxychloroquine Risk Found in Some Older Patients With RA - 1 day
Mashup Score:2
Hydroxychloroquine initiation in older patients with rheumatoid arthritis and heart failure was associated with an increased risk for cardiovascular events compared with...
-
Compared w/ methotrexate, hydroxychloroquine could heighten the risk of major adverse CV events among older patients w/ rheumatoid arthritis & heart failure or a high #HeartFailure risk, a new #JACC study suggests. Read more in @Medscape: https://t.co/H5cJFa3m0W - view on twitter
Mashup Score:1
ForbesCancer Survivors At Higher Risk Of Cardiovascular Disease - 4 hours
Mashup Score:1
The increased risk is thought to be partially due to cardiotoxic side effects from some radiotherapy and chemotherapy...
-
Adult cancer survivors maintain a higher risk of #HeartDisease and #CVD compared to the general population, according to a new study in #JACC. @vickyyyf discusses the latest findings in @Forbes: https://t.co/jd58oMtDIB #CardioOnc - view on twitter
Mashup Score:1
MedPageTodayHCQ for RA: Not a Great Idea? - 3 hours
Mashup Score:1
Medicare data suggest increased heart...
-
A new study in #JACC found that the rates of #HeartFailure hospitalizations were significantly higher in patients with rheumatoid arthritis starting hydroxychloroquine. Read more in @medpagetoday: https://t.co/PGFgJIV5LW #cvPrev #CardioTwitter - view on twitter
Mashup Score:1
American College of CardiologyContact: Sam Roth, sroth@acc.org, WASHINGTON and DALLAS (Jun 23, 2022) – The American College of Cardiology and the American Heart Association have released a...
-
The ACC and the @American_Heart have released a comprehensive set of data standards to help standardize definitions and set the framework to capture and better understand how #COVID19 impacts cardiovascular health. Get more information here: https://t.co/77snnKm2Mr #CardioTwitter https://t.co/77snnKm2Mr - view on twitter
Mashup Score:1
MedscapeMedicare Cost Sharing May Put Quadruple HF Therapy Out of Reach - 1 week
Mashup Score:1
Patients’ out-of-pocket costs are highest for the most effective...
-
According to new findings published in #JACC, out-of-pocket costs were significantly higher for Medicare enrollees receiving quadruple drug therapy for #HFrEF than regimens limited to generic medications. Read more in @Medscape: https://t.co/eOF7yPZpaO #SGLT2 #HeartFailure - view on twitter
June 23, 2022—The American College of Cardiology (ACC) and the American Heart Association (AHA) announced the release of a comprehensive set...
ACC and @American_Heart released the “2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19” in #JACC and @CircOutcomes. Find out more in @cardiacinterv: https://t.co/yXObcwGsNE #COVID19 - view on twitter